Related Experiment Videos
Diabetes: preventing coronary heart disease in a high risk group
1Beta Cell Diabetes Centre and Lipid Clinic, Chelsea and Westminster Hospital, London SW10 9NH, UK. michael.feher@chelwest.nhs.uk
Abstract:
Cardiovascular disease is the major cause of morbidity and mortality in patients with type 2 diabetes. Numerous outcome trials have demonstrated clinical benefits from effective treatment of individual cardiovascular risk factors in patients with diabetes. These trials have provided the basis for current treatment guidelines and targets. More recently, multifactorial intervention strategies have shown a reduction in both cardiovascular and microvascular events in patients with type 2 diabetes. However, full implementation of a truly multifactorial strategy into routine practice remains an ideal due to practical difficulties of sustained implementation and associated costs. These practical issues relating to the treatment of diabetes and its complications are now in a greater spotlight due to the growing number of patients requiring treatment.
Insights
Managing type 2 diabetes involves addressing cardiovascular disease, a leading cause of death. Multifactorial interventions show promise, but practical challenges hinder widespread implementation in routine care.
Area of Science:
- Endocrinology and Metabolism
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is a primary cause of morbidity and mortality in type 2 diabetes (T2D) patients.
- Established guidelines for T2D management focus on treating individual cardiovascular risk factors.
- Growing T2D prevalence necessitates addressing treatment challenges and complications.
Purpose of the Study:
- To review the role of cardiovascular risk factor management in type 2 diabetes.
- To evaluate the impact of multifactorial intervention strategies on cardiovascular and microvascular events.
- To discuss the practical challenges and costs associated with implementing comprehensive T2D care.
Main Methods:
- Review of numerous outcome trials on cardiovascular risk factor treatment in diabetes.
- Analysis of studies investigating multifactorial intervention strategies in T2D.
- Discussion of implementation science principles related to sustained clinical practice changes.
Main Results:
- Effective treatment of individual risk factors yields clinical benefits in T2D patients.
- Multifactorial interventions demonstrate a reduction in both cardiovascular and microvascular events.
- Significant practical difficulties and costs impede the routine implementation of multifactorial strategies.
Conclusions:
- While multifactorial interventions are effective, their widespread adoption in clinical practice faces substantial hurdles.
- Addressing the practical and economic aspects of diabetes care is crucial given the increasing patient numbers.
- Further research and innovative approaches are needed to overcome implementation barriers for optimal T2D management.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Diabetic Nephropathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...